Oocyte quality

Oocyte quality, frequently referred to as egg quality, is a clinical and biological term describing the intrinsic potential of a female gamete to successfully undergo fertilization and develop into a viable embryo [2, 16]. It is not a single molecular target like a receptor or enzyme but rather a complex physiological phenotype determined by factors such as the oocyte's chromosomal normality (euploidy), mitochondrial bioenergetics, and the biochemical composition of the surrounding follicular fluid [1, 10]. As women age, oocyte quality naturally declines due to increased rates of meiotic errors and accumulated oxidative damage to cellular organelles [2, 11]. In the context of reproductive medicine and assisted reproductive technology (ART), oocyte quality is a primary determinant of pregnancy success. Therapeutic interventions do not target 'egg quality' directly but instead aim to optimize the follicular environment using gonadotropins for cycle regulation or antioxidants like Coenzyme Q10 and melatonin to mitigate oxidative stress and improve mitochondrial function [5, 7, 8]. While various biomarkers such as Anti-Müllerian Hormone (AMH) and specific gene expression profiles in cumulus cells are used to predict quality, the trait remains a multifaceted outcome of numerous interlocking signaling pathways [1, 4, 6].

Other names

Egg qualityOocyte competenceDevelopmental competenceEgg health

Enhancement of oocyte quality is achieved through the hormonal stimulation of folliculogenesis, reduction of oxidative stress within the follicular microenvironment, and the support of mitochondrial bioenergetics to facilitate proper chromosomal segregation and early embryonic cleavage events [5, 11].